During the three years of this study, a total of 300 women (cases with breast cancer and controls with a normal mammogram) aged 65 and older will be recruited from oncology and radiology offices to participate in a study consisting of one clinic visit. 展开 关键词:...
More than one-third of women still present with obviously advanced or , but both studies showed this has no association with socio-economic status. Late stage at presentation is a serious problem, and although mass screening is likely to cause an improvement in those who are screened, it ...
Examining the distribution of breast cancer (BC) stage and molecular subtype among women aged below (< 45 years), within (45–65
Mangone, LuciaBisceglia, IsabellaMichiara, MariaMusolino, AntoninoMazzoleni, GuidoCaldarella, AdeleMinerba, SanteCascone, GiuseppeBella, FrancescaDinaro, YleniaBreast Cancer: Targets & Therapy
Alzheimer's disease (AD) is a devastating neurodegenerative condition with no known cure. While current therapies target late-stage amyloid formation and c... S Chakroborty,C Briggs,MB Miller,... - 《Plos One》 被引量: 86发表: 2012年 Stage II breast cancer is not simply a late stage ...
CMF + radiotherapy in the primary treatment of operable breast cancer: preliminary results of a phase II pilot study Background and Objectives: Chemotherapy and radiotherapy have been investigated in several studies about their role in primary (neoadjuvant) treatment befo... R Bellantone,CP Lombardi...
A randomized clinical study of 187 patients with T1, T2 breast cancer was performed, in order to compare the effects of modified radical mastectomy (MRM) and breast conserving therapy (BCT) on breast recurrence, overall survival, and disease-free survival. One hundred eighty seven patients with ...
The dose administered to the tumour bed is a risk-factor for local recurrence in localised breast cancer following breast-conserving surgery. All patients (n=94) received 50 Gy external beam radiotherapy and one application of 700 cGy at 85% isodose with high dose rate brachytherapy. Of the ...
Even today, investigators continue to search for a subset of breast cancer patients who will have better disease control with radical surgery. BCT stands as not only the best-studied example of organ-conserving therapy but one of the most rigorously tested therapies in all of medicine. Breast-...
Findings from numerous studies have demonstrated the prognostic value of measuring Ki-67 in breast cancers.17 In one of the largest retrospective studies, in which investigators analyzed data from a regional population-based cancer registry (N = 3568), the Ki-67 index was a prognostic factor for...